
Biju Parekkadan, PhD
Assistant Professor of Surgery
Department of Surgery
Harvard Medical School
Assistant in Bioengineering
Massachusetts General Hospital
Dr. Parekkadan serves as an Assistant Professor of Surgery at Massachusetts General Hospital / Harvard Medical School and is an affiliated faculty member of the Harvard Stem Cell Institute and the Broad Institute. His laboratory has expertise is in engineering cell and gene therapeutics for translation. In complement to new therapeutic platforms, his group also applies engineering methods to create new assays for biomarker and drug discovery. He also has experience in technology transfer and translation in his service on several scientific advisory boards and as a co-founder of Sentien Biotechnologies, Inc., a maker of cell therapeutics. In acknowledgements for his efforts in scientific innovation and training, he was recognized by Harvard Medical School as Young Mentor of the Year and the U.S. Department of Health and Human Services with a Presidential Early Career Award for Scientists and Engineers, the highest honor given by the US government for early career investigators.
He received a BS in Biomedical Engineering from Rutgers University (2003) and a PhD in Chemical and Medical Engineering from MIT while completing all MD coursework at Harvard Medical School (2008).
Representative publications
Fletcher AL, Elman J, Astarita J, Murray R, Saeidi N, D’Rozario J, et al. Lymph node fibroblastic reticular cell transplants show robust therapeutic efficacy in models of high-mortality murine sepsis. Sci Trans Med. 2014 Aug; 6(249):249. PubMed PMID: 25122637
Milwid JM, Elman JS, Li M, Shen K, Manrai A, Gabow A, et al. Enriched protein screening of human bone marrow mesenchymal stromal cell secretions reveals MFAP5 and PENK as novel IL-10 modulators. Mol Therapy. 2014 May;22(5):999-1007. PubMed PMID: 24496384; PubMed Central PMCID: PMC4017089
Patel SJ, Milwid JM, King KR, Bohr S, Iracheta-Velle A, Li M, et al. Erratum: Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure. Nat Biotechnol. 2012 Jan; 30(2):179-83. PubMed PMID: 22252509; PubMed Central PMCID: PMC3609650
Elman JS, Murray RM, Wang F, Shen K, Gao S, Conway KE, et al. Pharmacokinetics of natural and engineered secreted factors delivered by mesenchymal stromal cells. PLoS One. 2014 Feb; 9(2):e89882. PubMed PMID: 24587097; PubMed Central PMCID: PMC3931832
Lee J, Li M, Milwid J, Dunham J, Vinegoni C, Gorbatov R, et al. Implantable microenvironments to attract hematopoietic stem/cancer cells. Proc Natl Acad Sci U S A. 2012 Nov; 109(48):19638-43. PubMed PMID: 23150542; PubMed Central PMCID: PMC3511730
Information
Biju Parekkadan, Ph.D.
Massachusetts General Hospital
Center for Engineering in Medicine
51 Blossom St.
Boston, MA 02114
View Biju’s Harvard Catalyst profile